These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 32151208)

  • 1. Clinical vs Microscopic Extranodal Extension and Survival in Oropharyngeal Carcinoma in the Human Papillomavirus Era.
    Gal TJ; O'Brien KJ; Chen Q; Huang B
    Otolaryngol Head Neck Surg; 2020 May; 162(5):693-701. PubMed ID: 32151208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extranodal extension is a strong prognosticator in HPV-positive oropharyngeal squamous cell carcinoma.
    Bauer E; Mazul A; Chernock R; Rich J; Jackson RS; Paniello R; Pipkorn P; Oppelt P; Gay H; Daly M; El-Mofty S; Thorstad W; Adkins D; Zevallos J
    Laryngoscope; 2020 Apr; 130(4):939-945. PubMed ID: 31077394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinoma.
    An Y; Park HS; Kelly JR; Stahl JM; Yarbrough WG; Burtness BA; Contessa JN; Decker RH; Koshy M; Husain ZA
    Cancer; 2017 Jul; 123(14):2762-2772. PubMed ID: 28323338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of Mortality in HPV-Associated Oropharynx Carcinoma Treated With Surgery Alone.
    Han M; Stanford-Moore GB; Larson AR; Schoppy DW; Cognetti DM; Joshi AS; Houlton JJ; Ryan WR
    Laryngoscope; 2020 Jul; 130(7):E423-E435. PubMed ID: 31675132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Lymph Node Yield on Survival in Surgically Treated Oropharyngeal Squamous Cell Carcinoma.
    Gomez ED; Chang JC; Ceremsak JJ; Brody RM; Brant JA; Rassekh CH; Weinstein GS; Newman JG
    Otolaryngol Head Neck Surg; 2021 Jan; 164(1):146-156. PubMed ID: 32689888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of Pathologic Extranodal Extension and Other Adverse Features After Transoral Robotic Surgery in Patients With HPV-Positive Oropharynx Cancer.
    Zebolsky AL; George E; Gulati A; Wai KC; Carpenter P; Van Zante A; Ha PK; Heaton CM; Ryan WR
    JAMA Otolaryngol Head Neck Surg; 2021 Dec; 147(12):1080-1088. PubMed ID: 34673904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Impact of High-Risk Pathologic Features in HPV-Related Oropharyngeal Squamous Cell Carcinoma and Tobacco Use.
    Kompelli AR; Morgan P; Li H; Harris W; Day TA; Neskey DM
    Otolaryngol Head Neck Surg; 2019 May; 160(5):855-861. PubMed ID: 30526292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Value of Radiologic Extranodal Extension in Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma.
    Lee B; Choi YJ; Kim SO; Lee YS; Hong JY; Baek JH; Lee JH
    Korean J Radiol; 2019 Aug; 20(8):1266-1274. PubMed ID: 31339014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Appraisal of the AJCC 8th edition pathologic staging modifications for HPV-positive oropharyngeal cancer, a study of the National Cancer Data Base.
    Zhan KY; Eskander A; Kang SY; Old MO; Ozer E; Agrawal AA; Carrau RL; Rocco JW; Teknos TN
    Oral Oncol; 2017 Oct; 73():152-159. PubMed ID: 28939068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Core Biopsy With Extranodal Extension in Surgically Treated Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma.
    Zhu VL; Rand DR; Arnold KE; Pagedar NA; Bayon R; Buchakjian MR
    JAMA Otolaryngol Head Neck Surg; 2023 Nov; 149(11):955-960. PubMed ID: 37433026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detailed Analysis of Clinicopathologic Factors Demonstrate Distinct Difference in Outcome and Prognostic Factors Between Surgically Treated HPV-Positive and Negative Oropharyngeal Cancer.
    Iyer NG; Dogan S; Palmer F; Rahmati R; Nixon IJ; Lee N; Patel SG; Shah JP; Ganly I
    Ann Surg Oncol; 2015 Dec; 22(13):4411-21. PubMed ID: 25801358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting Adverse Histopathology and Need for Postsurgical Adjuvant Therapy for Human Papilloma Virus-Associated Oropharynx Carcinoma.
    Ochoa E; Stanford-Moore G; Fakhry C; Ryan WR
    Otolaryngol Head Neck Surg; 2021 Aug; 165(2):309-316. PubMed ID: 33399518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of Patients With Single-Node Metastasis of Human Papillomavirus-Related Oropharyngeal Cancer Treated With Transoral Surgery.
    Chen SY; Sinha P; Last A; Ettyreddy A; Kallogjeri D; Pipkorn P; Rich JT; Zevallos JP; Paniello R; Puram SV; Van Abel K; Moore EJ; Oppelt P; Palka K; Adkins D; Daly M; Gay H; Thorstad WL; Jackson RS
    JAMA Otolaryngol Head Neck Surg; 2021 Jan; 147(1):16-22. PubMed ID: 33151273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary surgery for human papillomavirus-associated oropharyngeal cancer: Survival outcomes with or without adjuvant treatment.
    Cramer JD; Ferris RL; Kim S; Duvvuri U
    Oral Oncol; 2018 Dec; 87():170-176. PubMed ID: 30527235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of Care and Comparative Effectiveness of Intensified Adjuvant Therapy for Resected Oropharyngeal Squamous Cell Carcinoma in the Human Papillomavirus Era.
    Sher DJ; Nedzi L; Khan S; Hughes R; Sumer BD; Myers LL; Truelson JM; Koshy M
    JAMA Otolaryngol Head Neck Surg; 2016 Aug; 142(8):777-88. PubMed ID: 27368076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic impact of extranodal extension (ENE) in surgically managed treatment-naive HPV-positive oropharyngeal squamous cell carcinoma with nodal metastasis.
    Xu B; Saliba M; Alzumaili B; Alghamdi M; Lee N; Riaz N; Patel SG; Ganly I; Dogan S; Ghossein RA; Katabi N
    Mod Pathol; 2022 Nov; 35(11):1578-1586. PubMed ID: 35690646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Staging HPV-related oropharyngeal cancer: Validation of AJCC-8 in a surgical cohort.
    Geltzeiler M; Bertolet M; Albergotti W; Gleysteen J; Olson B; Persky M; Gross N; Li R; Andersen P; Kim S; Ferris RL; Duvvuri U; Clayburgh D
    Oral Oncol; 2018 Sep; 84():82-87. PubMed ID: 30115481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncologic outcomes of selective neck dissection in HPV-related oropharyngeal squamous cell carcinoma.
    Zenga J; Jackson RS; Graboyes EM; Sinha P; Lindberg M; Martin EJ; Ma D; Thorstad WL; Rich JT; Moore EJ; Haughey BH
    Laryngoscope; 2017 Mar; 127(3):623-630. PubMed ID: 27634021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors and survival unique to surgically treated p16+ oropharyngeal cancer.
    Haughey BH; Sinha P
    Laryngoscope; 2012 Sep; 122 Suppl 2():S13-33. PubMed ID: 22926949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. National treatment trends in human papillomavirus-positive oropharyngeal squamous cell carcinoma.
    Zhan KY; Puram SV; Li MM; Silverman DA; Agrawal AA; Ozer E; Old MO; Carrau RL; Rocco JW; Higgins KM; Enepekides DJ; Husain Z; Kang SY; Eskander A
    Cancer; 2020 Mar; 126(6):1295-1305. PubMed ID: 31825543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.